Pfizer gets Rs 1.26 cr tax penalty on transfer pricing audit

Regulatory & Legal View source PDF Explain this filing

PFIZER · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.9%Reaction day

₹3975.00

prior close

₹3950.10

announcement price

In-mkt

timing

Nifty Smallcap 250market-0.6%-1.2% vs market

Pharmaceuticals peers, median of 173sector+0.5%-2.3% vs sector

On the reaction day the stock moved 1.2 pts less than Nifty Smallcap 250 and 2.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.0

10m

+0.1

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.9-0.6-1.2+0.5-2.3

Next day

-2.5-0.4-2.2-0.3-2.2

-3.0-1.5-1.4-1.3-1.6

-2.8-1.2-1.6-1.6-1.2

-2.9+0.2-3.1-1.0-1.9

-4.1+0.3-4.4-1.1-3.1

-4.4-1.6-2.8-3.2-1.2

15d

-7.4-5.6-1.7-7.2-0.2

-5.4-4.3-1.1-5.1-0.3

—————

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Pfizer Ltd received an order on Sep 28, 2026 from the Income Tax Transfer Pricing authority levying a penalty of Rs 1.26 crore for Assessment Year 2023-24. The penalty was issued under Section 271G of the Income Tax Act for alleged non-furnishing of granular information during the TP audit. The company believes the order is not maintainable and plans to appeal. It states there is no material impact on financials or operations.

Likely market impact

Minor penalty, immaterial to financials. Company plans to appeal and expects no material impact on operations.